NovaBridge Biosciences (ADR) (NBP) Live Share Price, Invest From India

NovaBridge Biosciences (ADR) Stock Performance

as on June 27, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.58
Day's Price Range
$1.63
$1.64
3.66%
Downside
-0.61%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$1.64
100.00%
Downside
-100.00%
Upside

NovaBridge Biosciences (ADR) share price movements today

Previous Close: $1.60
Open: $1.59
Volume: 320.1K
Day's Low - High: $1.58 - $1.63

NovaBridge Biosciences (ADR) Historical Returns

1 Month Return: -13.98 %
3 Month Return: -37.25 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

NovaBridge Biosciences (ADR) Stock Fundamentals & Key Indicators

Check NovaBridge Biosciences (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$189.7M

EPS (TTM)

-0.94

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-40.89%

NovaBridge Biosciences (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NovaBridge Biosciences (ADR) with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
NovaBridge Biosciences (ADR)	NA	$189.7M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Indian Investors' Interest in NovaBridge Biosciences (ADR) Stock

Search interest for NovaBridge Biosciences (ADR) Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:67% versus previous 30 day period

NovaBridge Biosciences (ADR) Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	1	1	-	-	-	-	-	1	-
Gross Profit	1	-19	-	-	-	-	-	-19	-
Operating Income	335	-90	-17	-12	-13	-5	-7	-8	-72
EBITDA	-275	-84	-103	-6	-	-5	-7	-8	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	0	0	-	-	0	0
Income Before Tax	-456	-69	-49	-20	-10	-3	-5	-6	-72
Income Tax Expense	-	-	-42	-	-	-	-	-	-
Net Income	-346	20	25	-20	-9	-3	-5	-6	-30
Net Profit Margin	-29657.67%	1835.25%	0.00%	0.00%	0.00%	0.00%	0.00%	-601.24%	0.00%

NovaBridge Biosciences (ADR) Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	11	53	30	1,542	13	-1	0	-	-
Gross Profit	11	53	30	1,542	6	-1	0	-	0
Operating Income	-273	-455	-1,464	155	-2,071	-366	-511	-375	-13
EBITDA	-279	-431	-197	168	-2,057	-51	-344	-373	-13
Interest Expense	0	1	0	0	-	0	0	-	-
Depreciation	-	-	-	-	5	1	1	0	0
Income Before Tax	-290	-416	-1,451	483	-2,332	-973	-1,465	-362	-12
Income Tax Expense	-	1	-	12	0	0	-1,258	-	-
Net Income	-298	-402	-1,448	470	-366	-359	-205	-162	-6
Net Profit Margin	-2647.41%	-749.02%	-4826.77%	30.53%	-2648.70%	23438.90%	-32674.02%	0.00%	0.00%

NovaBridge Biosciences (ADR) Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	20	180	-143	-9	-22	-13	-48	-30	-72
Operating Cash Flow	-	-	8	-10	-	-	13	-14	-14
Investing Cash Flow	-	-	-	-	-	-	0	-	-
Financing Cash Flow	-	-	-	-	-	-	433	-3	-3
Change in Cash	-	-	-72	-11	-	-	446	-17	-17

NovaBridge Biosciences (ADR) Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-402	-1,451	470	-2,331	-2,507	-208	-362	-88
Operating Cash Flow	-280	-867	433	-973	-1,102	-72	-384	-20
Investing Cash Flow	9	212	-201	-727	458	-107	-992	104
Financing Cash Flow	1,479	152	3,440	593	42	-8	-2	57
Change in Cash	1,268	-487	3,565	-1,235	-212	-151	-1,706	142

Global Institutional Holdings in NovaBridge Biosciences (ADR)

Funds	Holdings
Citadel Advisors Llc	0.14%
The Goldman Sachs Group Inc	0.1%
Siren, L.L.C.	2.59%
Candriam Luxembourg S.C.A.	0.98%
HHG PLC	5.22%

See all

Insights on NovaBridge Biosciences (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, NBP stock has moved up by 9.3%
NO EFFECT
Against Peers
In the last 3 years, NovaBridge Biosciences American Depositary Shares has experienced a drawdown of -47.3%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 35.7%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 57.7%

About NovaBridge Biosciences (ADR)

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies; Phase 1b clinical trial in combination with nivolumab and chemotherapy in first-line gastric cancer. The company also develops VIS-101, VEGF-A × ANG-2 bispecific biologics in Phase 2 clinical trial to treat wet age-related macular degeneration and other retinal diseases, including diabetic macular edema; ragistomag, which is in Phase 1clinical trial for multiple solid tumors. It has a licensing agreement with AskGene to develop and commercialize VIS-101; collaborations with Bristol Myers Squibb for the development of givastomig; and license and collaboration agreement with AbbVie Ireland Unlimited Company for the development and commercialization of lemzoparlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

Organisation	NovaBridge Biosciences (ADR)
Headquarters	2440 Research Boulevard, Rockville, MD, United States, 20850
Industry	Biotechnology
CEO	Dr. Xi-Yong Fu M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of NovaBridge Biosciences (ADR)

Name	Title
Dr. Xi-Yong Fu M.B.A., Ph.D.	CEO & Director
Mr. Mark Hagler	President & Chief Commercial Officer
Mr. Tyler Ehler	Senior Director of Investor Relations
Ms. Liwei Lin	General Counsel & Board Secretary
Dr. Cong Xu M.D., Ph.D.	Senior VP and Head of R&D Center of Excellence
Dr. Phillip Dennis M.D., Ph.D.	Chief Medical Officer
Mr. Ming Lei	Chief Financial Officer
Mr. Sean Wuxiong Cao M.B.A., Ph.D.	Chief Business Development Officer & Director

FAQs

What is NovaBridge Biosciences (ADR) share price today?

NovaBridge Biosciences (ADR) share price today is $1.64 as on June 27, 2026 at 8:46 am IST at the close of the market. NovaBridge Biosciences (ADR) share today touched a day high of $1.63 and a low of $1.58.

What is the 52 week high and 52 week low for NovaBridge Biosciences (ADR) share?

NovaBridge Biosciences (ADR) share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. NovaBridge Biosciences (ADR) stock price today i.e. June 27, 2026 at 8:46 am IST is closed at $1.64,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is NovaBridge Biosciences (ADR)'s market capitalisation today?

NovaBridge Biosciences (ADR) market capitalisation is $0.00T as on June 27, 2026 at 8:46 am IST.

How to invest in NovaBridge Biosciences (ADR) Stock (NBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for NovaBridge Biosciences (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NovaBridge Biosciences (ADR) Shares that will get you 0.9146 shares as per NovaBridge Biosciences (ADR) share price of $1.64 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy NovaBridge Biosciences (ADR) Stock (NBP) from India?

Indian investors can start investing in NovaBridge Biosciences (ADR) (NBP) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 1:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in NovaBridge Biosciences (ADR) stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 1:40 am IST). Based on NovaBridge Biosciences (ADR) share’s latest price of $1.64 as on June 27, 2026 at 8:46 am IST, you will get 6.0976 shares of NovaBridge Biosciences (ADR). Learn more about fractional shares .